Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Exploring how social factors influence pain expression and assessment

Official title: Sociocultural & Biobehavioral Influences on Pain Expression and Assessment

Run by National Institutes of Health Clinical Center (CC) · NCT03258580 · Data updated 2026-11-12

This study is trying to see how social factors affect how people show and report pain, especially in disadvantaged groups, to find better ways to assess and treat pain fairly.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment700 (estimated)
SponsorNational Institutes of Health Clinical Center (CC)
NIH
Locations1 site (Bethesda, Maryland)
StatusRecruiting
StartedMay 9, 2018
Main results expectedMay 17, 2027
Study endsMay 30, 2027
Registry record updatedOctober 20, 2026
Trial IDNCT03258580 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy adults aged 18 to 60 who are fluent in English and can provide informed consent.

Probably not a fit

Patients with major medical conditions, mood disorders, or those who do not reside in the United States may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the behavioral, psychophysiological, and social processes that contribute to biases and disparities in pain experiences and treatment. It focuses on how interpersonal dynamics, such as pain expression and assessment, may differ across various demographics, particularly among disadvantaged populations. The research employs interventions like thermal and electric stimulation, as well as pain assessment feedback, to evaluate these influences. By understanding these factors, the study aims to develop interventions that improve pain assessment accuracy and reduce biases in treatment.

Why it matters

Potential benefit: If successful, this research could lead to more equitable pain assessment and treatment for diverse populations.

How similar studies have gone: Other studies have indicated that addressing social factors in pain assessment can lead to improved outcomes, suggesting this approach has potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
* INCLUSION CRITERIA:

All Sub-Studies:

* Healthy
* Between 18 and 60 years old
* Fluent in English
* Able to provide written informed consent

EXCLUSION CRITERIA:

All Sub-Studies:

* Unable to comply with study procedures
* Has a major-medical condition or medical history that in a clinician's assessment could affect ability to comply with study procedures, including neurological conditions (including stroke, blindness or deafness, or a history of brain damage)
* Has a current mood disorder, anxiety disorder, or substance use disorder, or has a history of psychosis, hospitalization for a mental health condition, or recurrent psychiatric episodes.
* NIH staff member who is a subordinate/relative/co-worker of any investigator on the protocol
* Prior completion of a different sub-study within this protocol.
* Is born outside of the states or territories of the United States of America
* Does not currently reside in a state or territory of the United States of America

Sub-study 1:

* Has a major-medical condition or medical history that in a clinician's assessment could affect heat sensitivity or pain thresholds. This may include cardiovascular, autonomic, or neurological conditions or a chronic systemic disease (e.g., diabetes)
* Has a medical condition that in a clinician's assessment might affect somatosensation (e.g., Raynaud's disease, peripheral neuropathy, or circulatory disorder)
* Has a current chronic pain condition or has had chronic pain in the past (painful condition lasting more than six months)
* Has a dermatological condition affecting the testing region, such as scars, burns, or recent tattoos that might influence cutaneous sensibility
* Regular use of prescription medication that has a significant effect on pain or heat perception. Excluded medications include central-acting agents such as opiates (morphine, tramadol), antidepressants (amitriptyline, duloxetine, milnacipran), anticonvulsants (gabapentin, pregabalin), anxiolytics (barbituates, benzodiazepines), hypnotics (zolpidem, sodium oxybate), antipsychotics (valproate, lithium, olanzapine), antimigraine agents (sumatriptan, ergotamine), and muscle relaxants (cyclobenzaprine, carisoprodol). Use of analgesic medications, such as non-steroidal anti-inflammatories, salicylates, and acetaminophen, taken on an "as needed" basis is acceptable as long as the last dose was not taken was within 5 half-lives of testing.
* Is left handed

Sub-study 4, FMRI participants:

* Has a current chronic pain condition or has had chronic pain in the past (painful condition lasting more than six months)
* Is left-handed
* Any FMRI contraindications, including:

  * Ferromagnetic metal in the cranial cavity or eye, e.g. aneurysm clip, implanted neural stimulator, cochlear implant, ocular foreign body.
  * Implanted cardiac pacemaker or auto-defibrillator.
  * Insulin pump.
  * Irremovable body piercing.
* Pregnant women (based on urine test completed within 24 hours prior to scan).
* Those with an abnormality on a structural MRI that has functional consequences based on clinician assessment.

Where it's running

  • National Institutes of Health Clinical Center
    Bethesda, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Lauren Y Atlas, Ph.D. — National Center for Complementary and Integrative Health (NCCIH)
  • Study coordinator: Adebisi O Ayodele, C.R.N.P.
  • Email: bisi.ayodele@nih.gov
  • Phone: (301) 827-0415

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.